Vital Signs
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programA Machine Learning Approach to Continuous Vital Sign Data AnalysisN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
City TherapeuticsVitls Tego Device
Colorado TherapeuticsA Machine Learning Approach to Continuous Vital Sign Data Analysis
Clinical Trials (2)
Total enrollment: 605 patients across 2 trials
Vitls Feasibility Physiologic Monitoring
Start: Feb 2022Est. completion: May 2023
N/ACompleted
A Machine Learning Approach to Continuous Vital Sign Data Analysis
Start: Sep 2011Est. completion: May 2022605 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.